Prescribed List post-listing reviews

As part of reforms to the Prescribed List, we are introducing regular reviews of listed products. The reviews help ensure that privately insured Australians continue to have access to clinically effective devices that meet their healthcare needs.

Post-listing reviews

Through the Prescribed List reforms, we formalised post-listing reviews to safeguard the settings of the Prescribed List.

On 12 May 2022, the Prostheses List Advisory Committee (now the Medical Devices and Human Tissue Advisory Committee) supported pilot post-listing reviews for 4 groups of devices:

  • metal-backed patellae
  • surgical guides and biomodels
  • spinal cord stimulators
  • urogynaecological mesh (mid-urethral sling) devices.

We used the learnings from these reviews to inform the finalisation of our post-listing review framework.

Active reviews

Completed reviews

Post-listing review framework

We prepared a post-listing review framework to promote a consistent approach for all post-listing reviews.

The framework outlines how we:

  • identify devices that may be appropriate for a post-listing review
  • prioritise devices identified as appropriate for a post-listing review
  • determine the scope of a post-listing review
  • undertake a post-listing review
  • inform and consult with stakeholders and sponsors during the post-listing review
  • action the outcomes and actions arising from a post-listing review.

Contact

Prescribed List post-listing reviews

Please contact us for more information about post-listing reviews of products on the Prescribed List.
Date last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.